Cambridge Heart submits 510 application for Microvolt T-wave Alternans OEM Module Cambridge Center, Inc. , today announced that the business has completed the development phase of its Microvolt T-wave Alternans OEM Module, and has submitted a 510 program for regulatory approval with the U.S. Drug and Food Administration .Pigs, and mainly minipigs, represent a viable model for preclinical medication trials and long-term basic safety studies, says Jan Motlik, DVM, PhD, DSc, from the Laboratory of Cell Plasticity and Regeneration of the Institute of Pet Physiology and Genetics in Libechov, Czech Republic. Advantages include its huge brain size and lengthy lifespan. Genetic advances have been produced, including defining the porcine genome, with a 96 percent similarity between your porcine and individual huntingtin genes.